{"id":784804,"date":"2023-09-19T07:35:04","date_gmt":"2023-09-19T11:35:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/"},"modified":"2023-09-19T07:35:04","modified_gmt":"2023-09-19T11:35:04","slug":"vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/","title":{"rendered":"Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">PALO ALTO, Calif., Sept.  19, 2023  (GLOBE NEWSWIRE) &#8212; Vincerx Pharma, Inc. (Nasdaq: VINC),\u00a0a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that Vincerx\u2019s CEO Ahmed Hamdy, M.D. and the Management Team will participate in a panel presentation and one-on-one investor meetings at the Cantor Fitzgerald Global Healthcare Conference 2023, to be held in New York, NY, September 26-28, 2023.<\/p>\n<p>\n        <strong>Conference Presentation Details<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%;vertical-align: top\">Panel Date\/Time:<\/td>\n<td style=\"max-width:80%;width:80%;min-width:80%;vertical-align: top\">Wednesday, September 27, 2023 at 9:10 a.m. ET<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle\">Speaker:<\/td>\n<td style=\"vertical-align: middle\">CEO Ahmed Hamdy, M.D.<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle\">Investor Access:<\/td>\n<td style=\"vertical-align: middle\">\n            <a href=\"https:\/\/wsw.com\/webcast\/cantor19\/vinc\/2095632\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/cantor19\/vinc\/2095632<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle\">1X1 meetings<\/td>\n<td style=\"vertical-align: middle\">The Vincerx Management Team will be available for 1X1 meetings during the conference. Those interested in requesting a meeting should contact their Cantor Fitzgerald sales representative.<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <br \/>A copy of the Company corporate presentation is available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_-ifapWSrNQFURW688fQTYCo9LF6LGmQjHyjK8F6Ax91eYd0rUqA1zLILUXqQ0yZR92C2hJJTx9K4aJc1fVXkJCzEGCCmBp-kwCs7MttRGmQWAJkuEyCRnyuC7um2wTz\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a> and a recording of the panel presentation can be accessed through the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pefc9X1uZy4root8Inyg3BhNvXtXiidyFwQIHWzHO7Nszur54r61xqBv8NCZ66PHTxaJA_pUHVowQ3-Q5sVDUyozF94d_cgdwHts0XaLSURsqvJGnaZldWPV1Alp1P--B-r5m5Nw78VbwD5hV1brcg==\" rel=\"nofollow noopener\" target=\"_blank\">Investor Calendar<\/a>\u201d section of the Vincerx website where it will be archived for 90 days.<\/p>\n<p>\n        <strong>About\u00a0Vincerx Pharma, Inc.<\/strong><br \/>\n        <br \/>Vincerx Pharma, Inc. (Vincerx) is a clinical-stage biopharmaceutical company committed to developing differentiated and novel therapies to address the unmet medical needs of patients with cancer. Vincerx has assembled a seasoned management team with a proven track record of successful oncology drug development, approvals, and value creation. The company\u2019s diverse pipeline consists of the next-generation antibody conjugate, VIP943, in Phase 1; small molecule drug-conjugate, VIP236, in Phase 1; preclinical antibody drug conjugate, VIP924; CDK9 inhibitor, enitociclib, currently in an NIH-sponsored Phase 1; and its next-generation modular bioconjugation platform.<\/p>\n<p>Vincerx is based in Palo Alto, California, and has a research facility in Monheim, Germany. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=i9Ek3pzd9V3CxUTFuOtbDecW1diSFMJPrQIfnYAklX96ff6pqFAcE1xWskMJMjGqIQKlbcCbwC81dJD6SbFQGg==\" rel=\"nofollow noopener\" target=\"_blank\"><strong>www.vincerx.com<\/strong><\/a>.<\/p>\n<p>\n        <strong>Contacts<\/strong>\n      <\/p>\n<p>Joyce Lonergan<br \/>LifeSci Advisors, LLC<br \/>781-528-5276<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nu2w6ZblHT-hykSBRaHs4fczGMB6dBzgabLRCsiApasy0kA4793r6lMoDWpi1B-TuyBEW7siEjColYaYxMM01wYhr_wDAyn7o1qI5gtYkoYyLgloQ17TgMjSlPBysI5l\" rel=\"nofollow noopener\" target=\"_blank\">jlonergan@lifesciadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDI3OCM1ODIwMzkxIzUwMDA3NDU2Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTllMGYxZjgtYjhkNy00YjkxLThkOGYtYmRhMTBmYTAyY2NiLTUwMDA3NDU2Mg==\/tiny\/Vincerx-Pharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PALO ALTO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) &#8212; Vincerx Pharma, Inc. (Nasdaq: VINC),\u00a0a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that Vincerx\u2019s CEO Ahmed Hamdy, M.D. and the Management Team will participate in a panel presentation and one-on-one investor meetings at the Cantor Fitzgerald Global Healthcare Conference 2023, to be held in New York, NY, September 26-28, 2023. Conference Presentation Details Panel Date\/Time: Wednesday, September 27, 2023 at 9:10 a.m. ET Speaker: CEO Ahmed Hamdy, M.D. Investor Access: https:\/\/wsw.com\/webcast\/cantor19\/vinc\/2095632 1X1 meetings The Vincerx Management Team will be available for 1X1 meetings during the conference. Those interested in requesting a meeting should contact their Cantor Fitzgerald sales representative. A &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-784804","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PALO ALTO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) &#8212; Vincerx Pharma, Inc. (Nasdaq: VINC),\u00a0a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that Vincerx\u2019s CEO Ahmed Hamdy, M.D. and the Management Team will participate in a panel presentation and one-on-one investor meetings at the Cantor Fitzgerald Global Healthcare Conference 2023, to be held in New York, NY, September 26-28, 2023. Conference Presentation Details Panel Date\/Time: Wednesday, September 27, 2023 at 9:10 a.m. ET Speaker: CEO Ahmed Hamdy, M.D. Investor Access: https:\/\/wsw.com\/webcast\/cantor19\/vinc\/2095632 1X1 meetings The Vincerx Management Team will be available for 1X1 meetings during the conference. Those interested in requesting a meeting should contact their Cantor Fitzgerald sales representative. A &hellip; Continue reading &quot;Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-19T11:35:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDI3OCM1ODIwMzkxIzUwMDA3NDU2Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023\",\"datePublished\":\"2023-09-19T11:35:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\\\/\"},\"wordCount\":293,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNDI3OCM1ODIwMzkxIzUwMDA3NDU2Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\\\/\",\"name\":\"Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNDI3OCM1ODIwMzkxIzUwMDA3NDU2Mg==\",\"datePublished\":\"2023-09-19T11:35:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNDI3OCM1ODIwMzkxIzUwMDA3NDU2Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNDI3OCM1ODIwMzkxIzUwMDA3NDU2Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/","og_locale":"en_US","og_type":"article","og_title":"Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023 - Market Newsdesk","og_description":"PALO ALTO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) &#8212; Vincerx Pharma, Inc. (Nasdaq: VINC),\u00a0a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that Vincerx\u2019s CEO Ahmed Hamdy, M.D. and the Management Team will participate in a panel presentation and one-on-one investor meetings at the Cantor Fitzgerald Global Healthcare Conference 2023, to be held in New York, NY, September 26-28, 2023. Conference Presentation Details Panel Date\/Time: Wednesday, September 27, 2023 at 9:10 a.m. ET Speaker: CEO Ahmed Hamdy, M.D. Investor Access: https:\/\/wsw.com\/webcast\/cantor19\/vinc\/2095632 1X1 meetings The Vincerx Management Team will be available for 1X1 meetings during the conference. Those interested in requesting a meeting should contact their Cantor Fitzgerald sales representative. A &hellip; Continue reading \"Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-19T11:35:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDI3OCM1ODIwMzkxIzUwMDA3NDU2Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023","datePublished":"2023-09-19T11:35:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/"},"wordCount":293,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDI3OCM1ODIwMzkxIzUwMDA3NDU2Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/","name":"Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDI3OCM1ODIwMzkxIzUwMDA3NDU2Mg==","datePublished":"2023-09-19T11:35:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDI3OCM1ODIwMzkxIzUwMDA3NDU2Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDI3OCM1ODIwMzkxIzUwMDA3NDU2Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-to-participate-at-the-cantor-fitzgerald-global-healthcare-conference-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/784804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=784804"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/784804\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=784804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=784804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=784804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}